Tripartite motif-containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR-1 and -2 and VEGFR2 in endothelial cells

FASEB Journal

Volumn 31, Issue 5, 2017, Pages 2026-2036

  Wang, Yinfang ^a   Li, Jinping ^a   Huang, Yitong ^a   Dai, Xiuqin ^a   Liu, Youbin ^a   Liu, Zongjun ^a   Wang, Ying ^b   Wang, Nanping ^c   Zhang, Peng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b MAYO GRADUATE SCHOOL   (United States)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

KMT5B; NF B; TRIM28

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TRIPARTITE MOTIF CONTAINING 28 PROTEIN; TRIPARTITE MOTIF PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2; IL8 PROTEIN, HUMAN; KDR PROTEIN, HUMAN; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; REPRESSOR PROTEIN; TRIM28 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; ENDOTHELIUM CELL; GENETICS; METABOLISM; MONOCYTE; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-8; MONOCYTES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 85019497606     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600988RR     Document Type: Article

References (59)

1. Costa, C., Incio, J., and Soares, R. (2007) Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10, 149-166
2. Imhof, B. A., and Aurrand-Lions, M. (2006) Angiogenesis and inflammation face off. Nat. Med. 12, 171-172
3. Mapp, P. I., and Walsh, D. A. (2012) Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat. Rev. Rheumatol. 8, 390-398
4. Coussens, L. M., and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867
5. Sainson, R. C., Johnston, D. A., Chu, H. C., Holderfield, M. T., Nakatsu,M.N.,Crampton, S. P., Davis, J.,Conn, E., andHughes, C.C. (2008) TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 111, 4997-5007
6. Bieler, G., Hasmim, M., Monnier, Y., Imaizumi, N., Ameyar, M., Bamat, J., Ponsonnet, L., Chouaib, S., Grell, M., Goodman, S. L., Lejeune, F., and Rüegg, C. (2007) Distinctive role of integrinmediated adhesion in TNF-induced PKB/Akt and NF-kappaB activation and endothelial cell survival. Oncogene 26, 5722-5732
7. Gao, B., Saba, T. M., and Tsan,M. F. (2002) Role of alpha(v)beta(3)-integrin in TNF-alpha-induced endothelial cell migration.Am. J. Physiol. Cell Physiol. 283, C1196-C1205
8. Zhang, R., Xu, Y., Ekman, N., Wu, Z., Wu, J., Alitalo, K., and Min, W. (2003) Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J. Biol. Chem. 278, 51267-51276
9. Zhou, X. F., Yu, J., Chang, M., Zhang,M., Zhou, D., Cammas, F., and Sun, S. C. (2012) TRIM28 mediates chromatin modifications at the TCRa enhancer and regulates the development of T and natural killer T cells. Proc. Natl. Acad. Sci. USA 109, 20083-20088
10. Santoni de Sio, F. R., Barde, I.,Offner, S., Kapopoulou, A., Corsinotti, A., Bojkowska, K., Genolet, R., Thomas, J. H., Luescher, I. F., Pinschewer, D.,Harris,N., andTrono, D. (2012)KAP1 regulates gene networks controlling T-cell development and responsiveness. FASEB J. 26, 4561-4575
11. Chikuma, S., Suita, N., Okazaki, I. M., Shibayama, S., and Honjo, T. (2012) TRIM28 prevents autoinflammatory T cell development in vivo. Nat. Immunol. 13, 596-603
12. Herzog, M., Wendling, O., Guillou, F., Chambon, P., Mark, M., Losson, R., and Cammas, F. (2011) TIF1b association with HP1 is essential for post-gastrulation development, but not for Sertoli cell functions during spermatogenesis. Dev. Biol. 350, 548-558
13. Santos, J., and Gil, J. (2014) TRIM28/KAP1 regulates senescence. Immunol. Lett. 162(1 Pt B), 281-289
14. Wei,C., Cheng, J., Zhou, B., Zhu, L., Khan,M.A., He,T., Zhou, S., He, J., Lu, X., Chen, H., Zhang, D., Zhao, Y., and Fu, J. (2016) Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein. Sci. Rep. 6, 29822
15. Addison, J. B., Koontz, C., Fugett, J. H., Creighton, C. J., Chen, D., Farrugia, M. K., Padon, R. R., Voronkova, M. A., McLaughlin, S. L., Livengood, R. H., Lin, C. C., Ruppert, J. M., Pugacheva, E. N., and Ivanov, A. V. (2015) KAP1 promotes proliferation and metastatic progression of breast cancer cells. Cancer Res. 75, 344-355
16. Chen, L., Muñoz-Antonia, T., and Cress, W. D. (2014) Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines. PLoS One 9, e101040
17. McNab, F. W., Rajsbaum, R., Stoye, J. P., and O'Garra, A. (2011) Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23, 46-56
18. Eames, H. L., Saliba, D. G., Krausgruber, T., Lanfrancotti, A., Ryzhakov, G., and Udalova, I. A. (2012) KAP1/TRIM28: an inhibitorof IRF5 functionininflammatorymacrophages. Immunobiology 217, 1315-1324
19. Liang, Q., Deng, H., Li, X., Wu, X., Tang,Q., Chang, T. H., Peng, H., Rauscher III, F. J., Ozato, K., and Zhu, F. (2011) Tripartite motifcontaining protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7. J. Immunol. 187, 4754-4763
20. Gjyshi, O., Roy,A.,Dutta, S., Veettil,M. V.,Dutta,D., andChandran, B. (2015) Activated Nrf2 interacts with Kaposi's sarcoma-associated herpesvirus latency protein LANA-1 and host protein KAP1 to mediate global lytic gene repression. J. Virol. 89, 7874-7892
21. Bentz,G.L.,Moss II,C.R.,Whitehurst,C.B.,Moody,C.A.,andPagano, J. S. (2015) LMP1-induced sumoylation influences themaintenance of Epstein-Barr virus latency through KAP1. J. Virol. 89, 7465-7477
22. Zhang,L., Zhu, C.,Guo, Y., Wei, F., Lu, J., Qin, J., Banerjee, S., Wang, J., Shang, H., Verma, S. C., Yuan, Z., Robertson, E. S., and Cai, Q. (2014) Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jk. J. Virol. 88, 6873-6884
23. Tsuruma, R., Ohbayashi, N., Kamitani, S., Ikeda, O., Sato, N., Muromoto,R., Sekine, Y.,Oritani,K., andMatsuda,T. (2008)Physical and functional interactions between STAT3 and KAP1. Oncogene 27, 3054-3059
24. Kamitani, S., Togi, S., Ikeda, O., Nakasuji,M., Sakauchi, A., Sekine, Y., Muromoto,R., Oritani, K., and Matsuda, T. (2011) Krüppel-associated box-associated protein 1 negatively regulates TNF-a-induced NF-kB transcriptional activity by influencing the interactions among STAT3, p300, and NF-kB/p65. J. Immunol. 187, 2476-2483
25. Coltrini, D., Di Salle, E., Ronca, R., Belleri,M., Testini, C., and Presta, M. (2013)Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR. Angiogenesis 16, 469-477
26. Bhattacharyya, S., Dudeja, P. K., and Tobacman, J. K. (2010) Tumor necrosis factor alpha-induced inflammation is increased but apoptosis is inhibited by commonfood additive carrageenan. J. Biol.Chem. 285, 39511-39522
27. Iyengar, S., Iyengar, S., and Farnham, P. J. (2011) KAP1 protein: an enigmatic master regulator of the genome. J. Biol. Chem. 286, 26267-26276
28. Narayan, K.,Waggoner, L., Pham, S. T., Hendricks, G. L., Waggoner, S. N., Conlon, J., Wang, J. P., Fitzgerald, K. A., and Kang, J. (2014) TRIM13 is a negative regulator of MDA5-mediated type I interferon production. J. Virol. 88, 10748-10757
29. Kimura, T., Jain, A., Choi, S. W., Mandell, M. A., Schroder, K., Johansen, T., and Deretic, V. (2015) TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J. Cell Biol. 210, 973-989
30. Hu,M.M.,Xie,X.Q., Yang, Q., Liao, C. Y., Ye, W., Lin, H., and Shu, H. B. (2015) TRIM38 negatively regulates TLR3/4-mediated innate immune and inflammatory responses by two sequential and distinct mechanisms. J. Immunol. 195, 4415-4425
31. Zhao, W., Wang, L., Zhang, M., Yuan, C., and Gao, C. (2012) E3 ubiquitin ligase tripartitemotif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptorassociated factor 6 in macrophages. J. Immunol. 188, 2567-2574
32. Zhao, W., Wang, L., Zhang, M., Wang, P., Yuan, C., Qi, J., Meng, H., and Gao, C. (2012) Tripartitemotif-containing protein 38 negatively regulates TLR3/4-and RIG-I-mediated IFN-b production and antiviral response by targeting NAP1. J. Immunol. 188, 5311-5318
33. Yoshimi, R., Chang, T. H.,Wang, H., Atsumi, T., Morse III,H. C., and Ozato, K. (2009) Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J. Immunol. 182, 7527-7538
34. Shi, M., Cho, H., Inn, K. S., Yang, A., Zhao, Z., Liang, Q., Versteeg, G. A., Amini-Bavil-Olyaee, S.,Wong, L. Y., Zlokovic, B. V., Park, H. S., García-Sastre, A., and Jung, J.U. (2014)Negative regulation ofNF-kB activity by brain-specific TRIpartite Motif protein 9. Nat. Commun. 5, 4820
35. Tanji, K., Kamitani, T., Mori, F., Kakita, A., Takahashi, H., and Wakabayashi, K. (2010) TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol. Dis. 38, 210-218
36. Neo, S. H., Itahana, Y., Alagu, J., Kitagawa, M., Guo, A. K., Lee, S. H., Tang, K., and Itahana, K. (2015) TRIM28 is an E3 ligase for ARFmediated NPM1/B23 SUMOylation that represses centrosome amplification. Mol. Cell. Biol. 35, 2851-2863
37. Alexander, K. A., Wang, X., Shibata, M., Clark, A. G., and García-García, M. J. (2015) TRIM28 controls genomic imprinting through distinct mechanisms during and after early genome-wide reprogramming. Cell Rep. 13, 1194-1205
38. Turelli, P., Castro-Diaz, N., Marzetta, F., Kapopoulou, A., Raclot, C., Duc, J., Tieng, V., Quenneville, S., and Trono, D. (2014) Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements. Genome Res. 24, 1260-1270
39. Li,Q., Yan, J., Mao, A. P., Li, C., Ran, Y., Shu, H. B., andWang, Y. Y. (2011) Tripartite motif 8 (TRIM8) modulates TNFa-and IL-1btriggered NF-kB activation by targeting TAK1 for K63-linked polyubiquitination. Proc.Natl. Acad. Sci. USA 108, 19341-19346
40. Kondo, T., Watanabe, M., and Hatakeyama, S. (2012) TRIM59 interacts with ECSIT and negatively regulates NF-kB and IRF-3/7-mediated signal pathways. Biochem. Biophys. Res. Commun. 422, 501-507
41. Noguchi, K.,Okumura, F., Takahashi, N., Kataoka, A., Kamiyama, T., Todo, S., and Hatakeyama, S. (2011) TRIM40 promotes neddylation of IKKg and is downregulated in gastrointestinal cancers. Carcinogenesis 32, 995-1004
42. Shibata,M., Sato,T.,Nukiwa,R.,Ariga,T., andHatakeyama, S. (2012) TRIM45 negatively regulates NF-kB-mediated transcription and suppresses cell proliferation. Biochem. Biophys. Res. Commun. 423, 104-109
43. Choi, U. Y., Hur, J. Y., Lee, M. S., Zhang, Q., Choi, W. Y., Kim, L. K., Lee,W.B.,Oh, G.T., andKim, Y. J. (2014)Tripartitemotif-containing protein 30 modulates TCR-activated proliferation and effector functions inCD4+Tcells (published correction in PLoSOne,May 27, 2014; 9:e99267. doi: 10.1371/journal.pone.0099267). PLoS One 9, e95805
44. Yan, J., Li, Q., Mao, A. P., Hu, M. M., and Shu, H. B. (2014) TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination. J. Mol. Cell Biol. 6, 154-163
45. Luo, Q., Lin, H., Ye, X., Huang, J., Lu, S., and Xu, L. (2015) Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-kB signaling pathway. Int. J. Clin. Oncol. 20, 508-517
46. Yu, S.,Gao,B.,Duan,Z.,Xu,W., andXiong, S. (2011) Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-kB activator. Biochem. Biophys. Res. Commun. 410, 247-251
47. Qiu, H., Huang, F., Xiao, H., Sun, B., and Yang, R. (2013) TRIM22 inhibits the TRAF6-stimulated NF-kB pathway by targeting TAB2 for degradation. Virol. Sin. 28, 209-215
48. Noort, A. R., van Zoest, K. P., Weijers, E. M., Koolwijk, P., Maracle, C. X.,Novack, D.V., Siemerink,M. J., Schlingemann, R.O., Tak, P. P., and Tas, S. W. (2014) NF-kB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis. J. Pathol. 234, 375-385
49. Noort, A. R., Tak, P. P., and Tas, S. W. (2015)Non-canonicalNF-kB signaling in rheumatoid arthritis:Dr Jekyll andMrHyde? Arthritis Res. Ther. 17, 15
50. Sun, S.C. (2011)Non-canonicalNF-kB signaling pathway. Cell Res. 21, 71-85
51. Razani, B., Zarnegar, B., Ytterberg, A. J., Shiba, T., Dempsey, P. W., Ware, C. F., Loo, J. A., and Cheng, G. (2010) Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation. Sci. Signal. 3, ra41
52. Bunch, H., Zheng, X., Burkholder, A., Dillon, S. T., Motola, S., Birrane,G., Ebmeier,C.C., Levine, S., Fargo, D.,Hu, G.,Taatjes, D. J., and Calderwood, S. K. (2014) TRIM28 regulates RNA polymerase II promoter-proximal pausing and pause release. Nat. Struct. Mol. Biol. 21, 876-883
53. Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., Sobke, A.,Herrmann,M., Preissner, K. T., Vajkoczy, P., and Augustin, H. G. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 12, 235-239
54. McNamara, R. P., Reeder, J. E., McMillan, E. A., Bacon, C. W., McCann, J. L., and D'Orso, I. (2016) KAP1 recruitment of the 7SK snRNP complex to promoters enables transcription elongation by RNA polymerase II. Mol. Cell 61, 39-53
55. Miles,D. C., Alexandra de Vries, N.,Gisler, S., Lieftink, C., Akhtar,W., Gogola, E., Pawlitzky, I., Hulsman, D., Tanger, E., Koppens, M., Leonardus Beijersbergen, R., and van Lohuizen, M. (2016) TRIM28 isanepigenetic barrier toinducedpluripotent stemcell reprogramming. Stem Cells 35, 147-157
56. Santoni de Sio, F.R.,Massacand, J.,Barde, I.,Offner, S.,Corsinotti,A., Kapopoulou, A., Bojkowska, K., Dagklis, A., Fernandez, M., Ghia, P., Thomas, J.H., Pinschewer, D.,Harris,N., and Trono, D. (2012) KAP1 regulates gene networks controlling mouse B-lymphoid cell differentiation and function. Blood 119, 4675-4685
57. Messerschmidt, D. M., de Vries, W., Ito, M., Solter, D., Ferguson-Smith, A., and Knowles, B. B. (2012) Trim28 is required for epigenetic stability during mouse oocyte to embryo transition. Science 335, 1499-1502
58. Luo, Y., Xu, Z., Wan, T., He, Y., Jones, D., Zhang, H., and Min, W. (2010)Endothelial-specific transgenesis ofTNFR2 promotes adaptive arteriogenesis and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 30, 1307-1314
59. Zhang,H., He, Y., Dai, S., Xu, Z., Luo, Y., Wan, T., Luo, D., Jones, D., Tang, S.,Chen,H., Sessa, W.C., andMin, W. (2008)AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. J. Clin. Invest. 118, 3904-3916